Nine patients with mild Tourette's syndrome completed a cross-over,
placebo-controlled study of clonidine administered transdermally. Although
the subjects showed no improvement on objective measures of symptom
severity, most subjects felt they had improved. Seven subjects chose to
continue taking clonidine. Larger, blinded studies of transdermal clonidine
are indicated.Abstract Teaser